Alpha Tau Medical (DRTS) CFO Raphi Levy reports detailed insider holdings
Rhea-AI Filing Summary
Alpha Tau Medical Ltd. executive Raphi Levy, the Chief Financial Officer, reports his current equity holdings in the company. He directly holds 180,180 ordinary shares, multiple option grants over ordinary shares with exercise prices ranging from 2.60 to 11.50 and expirations between 2029 and 2036, and several tranches of restricted share units.
The footnotes explain that certain restricted share unit grants vest in equal quarterly installments over three-year periods commencing January 1, 2024, January 1, 2025 and January 1, 2026, subject to his continued service. Some option grants are already fully vested, while others vest quarterly over similar three-year schedules tied to continued employment.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
Footnotes (1)
- These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2024, subject to the Reporting Person's continued service. These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2025, subject to the Reporting Person's continued service. These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in quarterly equal installments for a period of three years commencing January 1, 2026, subject to the Reporting Person's continued service. These are options to acquire ordinary shares, which have fully vested as of the date hereof. These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2024, subject to the Reporting Person's continued service. These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2025, subject to the Reporting Person's continued service. These are options to acquire ordinary shares, which options will vest in quarterly equal installments for a period of three years commencing January 1, 2026, subject to the Reporting Person's continued service.
FAQ
What does Alpha Tau Medical (DRTS) CFO Raphi Levy disclose in this Form 3?
Raphi Levy discloses his existing equity holdings in Alpha Tau Medical. He reports directly held ordinary shares, multiple option grants over ordinary shares, and several tranches of restricted share units with specified exercise prices, expiration dates, and vesting schedules tied to continued service.
Does this Alpha Tau Medical Form 3 show any insider buying or selling activity?
No insider buying or selling activity is shown; the entries are characterized as holdings. The transaction summary indicates zero buy or sell transactions, with all 16 entries treated as holding records rather than new purchases, sales, exercises, gifts or other disposition events.
What is the nature of Raphi Levy’s ownership of Alpha Tau Medical equity?
All reported positions are classified as direct ownership. This includes his ordinary shares, option grants over ordinary shares and restricted share units, without indications of indirect holdings through entities or disclaimers of beneficial ownership in the provided information.